{
    "2020-07-02": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Amgen Gets Favorable Appeals Court Ruling for Enbrel Patent",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Favorable",
                        "Appeals",
                        "Court",
                        "Ruling",
                        "Enbrel",
                        "Patent"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Novartis reaches $642m settlement with US authorities",
                "features": {
                    "keywords": [
                        "Novartis",
                        "settlement",
                        "US",
                        "authorities",
                        "$642m"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Settles",
                        "Lawsuit",
                        "$678M",
                        "Sarepta",
                        "Gene",
                        "Therapy",
                        "Unity",
                        "Biotech",
                        "Catalysts"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Novartis pays $729 mln in U.S. kickback charges",
                "features": {
                    "keywords": [
                        "Novartis",
                        "pays",
                        "$729",
                        "mln",
                        "U.S.",
                        "kickback",
                        "charges"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Novartis Settles $678M Fraud Lawsuit Alleging It Bribed Doctors At Company Speaker Events",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Settles",
                        "$678M",
                        "Fraud",
                        "Lawsuit",
                        "Bribed",
                        "Doctors",
                        "Speaker",
                        "Events"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Novartis pays $729 million to settle U.S. kickback charges",
                "features": {
                    "keywords": [
                        "Novartis",
                        "pays",
                        "$729",
                        "million",
                        "settle",
                        "U.S.",
                        "kickback",
                        "charges"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Stocks - Europe Seen Higher on Virus Vaccine Optimism",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Europe",
                        "Higher",
                        "Virus",
                        "Vaccine",
                        "Optimism"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}